ロード中...
Zonisamide add‐on therapy for focal epilepsy
BACKGROUND: The majority of people with epilepsy have a good prognosis, and their seizures can be well controlled with the use of a single antiepileptic agent, but up to 30% develop dug‐resistant epilepsy, especially those with focal seizures. In this review, we summarised the evidence from randomis...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2020
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7389315/ https://ncbi.nlm.nih.gov/pubmed/32715463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001416.pub5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|